| Jessika Scogland, | |
|
300 Broadway, Somerville, MA 02145-2935 | |
| (617) 575-5268 | |
| Not Available |
| Full Name | Jessika Scogland |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 300 Broadway, Somerville, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063077808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | (* (Not Available)) | Primary |
| Entity Name | Cambridge Public Health Commission |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487603585 PECOS PAC ID: 8921910894 Enrollment ID: O20040121000364 |
News Archive
Myogen today announced that the Commission of the European Communities, with a favorable opinion of the Committee for Orphan Medicinal Products of the European Medicines Agency (EMEA), has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension.
GPCRs are one of the largest families of cellular signalling proteins consisting of more than a thousand different types. They reside on the surface membranes of cells where they are poised to recognize molecules in the exterior environment and then transmit this information through the membrane allowing cells to respond accordingly.
Fresenius Medical Care North America (FMCNA), the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, is donating and delivering dialysis supplies to Haitians, at a time when relief supplies continue to be slow to reach those in need following a devastating earthquake and aftershock.
Blood pressure is effectively lowered by mindfulness-based stress reduction for patients with borderline high blood pressure or "prehypertension." This finding is reported in the October issue of Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
Infinity Pharmaceuticals, Inc. announced that results from its Phase 2 study of IPI-504, a novel IV-administered Hsp90 chaperone inhibitor, in patients with advanced non-small cell lung cancer (NSCLC) were published in the Journal of Clinical Oncology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessika Scogland, 17 Village View Rd, Westford, MA 01886-2359 Ph: (310) 994-1949 | Jessika Scogland, 300 Broadway, Somerville, MA 02145-2935 Ph: (617) 575-5268 |
News Archive
Myogen today announced that the Commission of the European Communities, with a favorable opinion of the Committee for Orphan Medicinal Products of the European Medicines Agency (EMEA), has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension.
GPCRs are one of the largest families of cellular signalling proteins consisting of more than a thousand different types. They reside on the surface membranes of cells where they are poised to recognize molecules in the exterior environment and then transmit this information through the membrane allowing cells to respond accordingly.
Fresenius Medical Care North America (FMCNA), the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, is donating and delivering dialysis supplies to Haitians, at a time when relief supplies continue to be slow to reach those in need following a devastating earthquake and aftershock.
Blood pressure is effectively lowered by mindfulness-based stress reduction for patients with borderline high blood pressure or "prehypertension." This finding is reported in the October issue of Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.
Infinity Pharmaceuticals, Inc. announced that results from its Phase 2 study of IPI-504, a novel IV-administered Hsp90 chaperone inhibitor, in patients with advanced non-small cell lung cancer (NSCLC) were published in the Journal of Clinical Oncology.
› Verified 4 days ago
Grace S Kim, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 26 Central St, Somerville, MA 02143 Phone: 617-575-5355 | |
Dr. Christopher Duane Welch, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 63 College Ave, Somerville, MA 02144 Phone: 617-629-6628 | |
John Francis Cusack, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 403 Highland Ave, Suite 211, Somerville, MA 02144 Phone: 617-666-5800 Fax: 617-666-5832 | |
Dr. Kimberly Faris, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 26 Central St, Somerville, MA 02143 Phone: 617-575-5335 | |
Thomas Stoddard, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 23 Kent Ct # 3, Somerville, MA 02143 Phone: 508-208-6605 | |
Ms. Tamara Joy Harper, M.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 57 Dimick St # 3, Somerville, MA 02143 Phone: 619-892-1001 |